Chris is the Managing Partner of Bridgepoint Europe. Chris also sits on the Firm’s Group Management Committee and is a member of its Investment Advisory Committee.
He currently sits on the board of Vermaat, and historical transactions include Element, PharmaZell, Vitamin Well, LGC, ERM, Pret A Manger and the delisting of Exova plc.
Chris has a BSc from Exeter University and is ACA qualified. Chris sits on the board of and is involved with charities in the Literacy and wider educational space.